全文获取类型
收费全文 | 33229篇 |
免费 | 2513篇 |
国内免费 | 465篇 |
专业分类
耳鼻咽喉 | 689篇 |
儿科学 | 561篇 |
妇产科学 | 697篇 |
基础医学 | 4616篇 |
口腔科学 | 514篇 |
临床医学 | 2720篇 |
内科学 | 7430篇 |
皮肤病学 | 970篇 |
神经病学 | 2393篇 |
特种医学 | 1733篇 |
外科学 | 4600篇 |
综合类 | 553篇 |
现状与发展 | 1篇 |
一般理论 | 19篇 |
预防医学 | 1408篇 |
眼科学 | 1003篇 |
药学 | 2879篇 |
中国医学 | 370篇 |
肿瘤学 | 3051篇 |
出版年
2023年 | 198篇 |
2022年 | 138篇 |
2021年 | 913篇 |
2020年 | 561篇 |
2019年 | 898篇 |
2018年 | 1063篇 |
2017年 | 756篇 |
2016年 | 961篇 |
2015年 | 1329篇 |
2014年 | 1563篇 |
2013年 | 1800篇 |
2012年 | 2610篇 |
2011年 | 2705篇 |
2010年 | 1632篇 |
2009年 | 1398篇 |
2008年 | 1995篇 |
2007年 | 1918篇 |
2006年 | 1722篇 |
2005年 | 1653篇 |
2004年 | 1375篇 |
2003年 | 1347篇 |
2002年 | 1200篇 |
2001年 | 768篇 |
2000年 | 699篇 |
1999年 | 654篇 |
1998年 | 233篇 |
1997年 | 216篇 |
1996年 | 189篇 |
1995年 | 189篇 |
1994年 | 162篇 |
1993年 | 106篇 |
1992年 | 329篇 |
1991年 | 238篇 |
1990年 | 278篇 |
1989年 | 265篇 |
1988年 | 253篇 |
1987年 | 213篇 |
1986年 | 195篇 |
1985年 | 172篇 |
1984年 | 148篇 |
1983年 | 120篇 |
1982年 | 86篇 |
1981年 | 80篇 |
1980年 | 77篇 |
1979年 | 134篇 |
1978年 | 91篇 |
1977年 | 71篇 |
1975年 | 63篇 |
1974年 | 56篇 |
1972年 | 53篇 |
排序方式: 共有10000条查询结果,搜索用时 265 毫秒
41.
42.
43.
Usefulness of endoscopic ultrasound‐guided sampling using core biopsy needle as a percutaneous biopsy rescue for diagnosis of solid liver mass: Combined histological‐cytological analysis 下载免费PDF全文
44.
Effect of topical vitamin D on chronic kidney disease‐associated pruritus: An open‐label pilot study 下载免费PDF全文
Kyung Eun Jung Yu Ri Woo Joong Sun Lee Jong Ho Shin Jin Uk Jeong Dae Won Koo Ki Tae Bang 《The Journal of dermatology》2015,42(8):800-803
Chronic kidney disease‐associated pruritus (CKD‐aP) is a troublesome symptom in patients with end‐stage renal disease (ESRD). Recently, vitamin D deficiency has been known to be one of the possible etiologic factors in CKD‐aP. However, limited data is available on whether topical vitamin D treatment is effective for relieving CKD‐aP. Therefore, the purpose of this study is to evaluate the effectiveness of topically vitamin D for CKD‐aP. Twenty‐three patients with CKD‐aP were enrolled in a single center, open‐label study. Patients were instructed to apply a topical vitamin D (calcipotriol) agent (Daivonex solution; LEO Pharma) or vehicle solution twice daily for a month. We assessed the efficacy and safety of topical vitamin D on CKD‐aP using clinical and dermoscopic photographs, and questionnaires including the validated modified pruritus assessment score (VMPAS) and visual analog scale (VAS) every 2 weeks. Dry dermoscopic findings showed significant improvement of scale (dryness) on the skin of topical vitamin D‐treated patients compared with those of the vehicle group. Both VMPAS and VAS were significantly decreased after 2 and 4 weeks of the topical vitamin D treatment compared with the vehicle, respectively (P < 0.05). No significant side‐effects were observed. Topical vitamin D may be one of the safe and effective therapeutic candidates for CKD‐aP. 相似文献
45.
Wan Kee Kim Ho Jin Kim Joon Bum Kim Sung-Ho Jung Suk Jung Choo Cheol Hyun Chung Jae Won Lee 《The Journal of thoracic and cardiovascular surgery》2019,157(4):1519-1528.e5
Objective
Efficacy of atrial fibrillation ablation in rheumatic mitral valve disease has been regarded inferior to that in nonrheumatic diseases. This study aimed to evaluate net clinical benefits by the addition of concomitant atrial fibrillation ablation in rheumatic mitral valve surgery.Methods
Among 1229 consecutive patients with atrial fibrillation from 1997 to 2016 (54.4 ± 11.7 years; 68.2% were female), 812 (66.1%) received concomitant ablation of atrial fibrillation (ablation group), and 417 (33.9%) underwent valve surgery alone (no ablation group). Death and thromboembolic events were compared between these groups. Mortality was regarded as a competing risk to evaluate thromboembolic outcomes. To reduce selection bias, inverse probability of treatment weighting methods were performed.Results
Freedom from atrial fibrillation occurrence at 5 years was 76.5% ± 1.8% and 5.3% ± 1.1% in the ablation and no ablation groups, respectively (P < .001). The ablation group had significantly lower risks for death (hazard ratio [HR], 0.69; 95% confidence interval [CI], 0.52-0.93) and thromboembolic events (HR, 0.49; 95% CI, 0.32-0.76) than the no ablation group. Time-varying Cox analysis revealed that the occurrence of stroke after surgery was significantly associated with death (HR, 3.97; 95% CI, 2.36-6.69). In subgroup analyses, the reduction in the composite risk of death and thromboembolic events was observed in all mechanical (n = 829; HR, 0.53; 95% CI, 0.39-0.73), bioprosthetic replacement (n = 239; HR, 0.67; 95% CI, 0.41-1.08), and repair (n = 161; HR, 0.17; 95% CI, 0.06-0.52) subgroups (P for interaction = .47).Conclusions
Surgical atrial fibrillation ablation during rheumatic mitral valve surgery was associated with a lower risk of long-term mortality and thromboembolic events. Therefore, atrial fibrillation ablation for rheumatic mitral valve disease may be a reasonable option. 相似文献46.
47.
Sun Hye Shin Hye Yun Park Yunjoo Im Hyun Ae Jung Jong-Mu Sun Jin Seok Ahn Myung-Ju Ahn Keunchil Park Ho Yun Lee Se-Hoon Lee 《International journal of cancer. Journal international du cancer》2019,145(9):2433-2439
Emerging immune profiling data suggest a higher sensitivity to immune checkpoint inhibitors (ICIs) in nonsmall cell lung cancer (NSCLC) patients with chronic obstructive pulmonary disease (COPD), compared to those without COPD. This study aimed to investigate the clinical impact of COPD on the treatment response to ICIs in a large number of patients with NSCLC. In total, 133 patients with spirometry test results were retrospectively identified among those who received palliative pembrolizumab for NSCLC. COPD was defined as pre-bronchodilator forced expiratory volume in 1 s/forced vital capacity <0.7. Overall survival (OS), progression-free survival (PFS), and objective response rate were analyzed according to the presence of COPD. Spirometry-based COPD was present in 59 (44%) patients. Patients with COPD had better OS (hazard ratio [HR] for death, 0.45; 95% confidence interval [CI], 0.26–0.78) and PFS (HR for disease progression or death, 0.50; 95% CI, 0.31–0.79) than those without COPD. These associations persisted after adjusting for potential confounders including smoking history. The response rate was also higher in patients with COPD than in those without COPD (38.2% vs. 20.5%, p = 0.028). Spirometry-defined COPD was associated with a significantly longer OS and PFS in patients with NSCLC treated with palliative pembrolizumab. Identifying coexisting COPD could predict favorable treatment outcomes in patients with NSCLC treated with pembrolizumab. 相似文献
48.
49.
50.
Cheng Shi Chen Alrashidi Ibrahim Ji Hoon Shin Hai-Liang Li Hye Hyeon Moon Hee Ho Chu Jong Woo Kim 《Journal of vascular and interventional radiology : JVIR》2021,32(1):135-140
Six patients (mean age, 57.7 y ± 19.7) with persistent urinary fistulae underwent 7 urinary tract embolizations with AMPLATZER Vascular Plugs (AVPs) and glue: 5 with concomitant cavity obliteration with glue and 2 without. A single procedure was successful in resolving urinary leakage in 5 patients (71%) at a mean follow-up of 27.3 wk ± 31.5 (median, 9.7 wk; range, 4.9–80 wk). Repeat cavity embolization was required in 2 instances to achieve clinical success. Mean survival was 42.3 wk (median, 16.4 wk; range, 11.7–104 wk). Combined AVP and glue embolization may prove to be a primary approach in the control of persistent fistulae. 相似文献